MAPKAPK2 and periodontitis: In our study, we hypothesized that silencing MK2 through an RNAi strategy would provide a novel anti-inflammatory target that selectively blocks signaling mechanisms needed for enhanced cytokine mRNA stability/translation in periodontitis progression.